Loading
Archives of Clinical Toxicology
ISSN: 2692-8280
Role of microbial volatile compounds (mVOCs) in toxicity from molds-infested buildings: a case report
Molds are ubiquitous, they grow optimally under high humidity, inadequate ventilation, and poor lighting, especially indoors. Components of molds (i.e., β-glucans from the cell wall of spores and hyphal fragments) and toxic metabolites they produce (e.g., mycotoxins and microbial volatile organic compounds, mVOCs) are known to cause adverse health effects in humans. Indoors, components of molds easily reach unsafe levels.
Arch Clin Toxicol, 2026, Volume 8, Issue 1, p1-5 | DOI: 10.46439/toxicology.8.044
The invisible century of toxic exposures: why clinical toxicology must reinvent itself
We are living in what future historians will call the invisible century of toxic exposures—an era in which the most dangerous poisons are no longer the ones we can see, smell, or even detect with routine diagnostics. Instead, they emerge silently from synthetic chemistry labs, global supply chains, industrial waste streams, micro-environments, household products, online marketplaces, and, increasingly, from the hands of those who synthesize psychoactive compounds faster than regulators can name them.
Arch Clin Toxicol, 2026, Volume 8, Issue 1, p6-7 | DOI: 10.46439/toxicology.8.045
Reconsidering the scientific validity of the term “non-toxic” in toxicological risk assessment
The term “non-toxic” is widely used in consumer product labeling despite the absence of a formal scientific or regulatory definition. Contemporary toxicology recognizes that adverse biological effects depend on dose, duration of exposure, route of entry, genetic variability, and underlying molecular mechanisms.
Arch Clin Toxicol, 2026, Volume 8, Issue 1, p8-10 | DOI: 10.46439/toxicology.8.046